Inne HM Borel Rinkes

University Hospital Heidelberg

Papers

1

Total Citations

179

H-Index

1

About

Inne HM Borel Rinkes is a pioneering surgical oncologist whose research has fundamentally advanced the treatment of esophageal cancer through minimally invasive techniques. Her landmark work centers on developing and validating robot-assisted surgical approaches, most notably demonstrated in the ROBOT trial—a randomized controlled trial comparing robot-assisted minimally invasive thoraco-laparoscopic esophagectomy with open transthoracic esophagectomy for resectable esophageal cancer. This seminal 2012 study, with 179 citations, provided critical evidence that robotic surgery could achieve comparable oncologic outcomes while reducing surgical trauma. Borel Rinkes’ contributions have helped shift the paradigm from traditional open esophagectomy—the global standard for en-bloc tumor and lymph node resection—toward less invasive approaches that improve patient recovery without compromising cancer clearance. Her work has been instrumental in establishing the safety and efficacy of robotic esophagectomy, influencing surgical protocols worldwide. Through rigorous clinical trials, she has demonstrated that innovation in surgical technique can enhance both oncologic precision and postoperative quality of life, making her a leading voice in the evolution of esophageal cancer surgery and a mentor to a generation of minimally invasive surgeons.

Research Focus

Key Achievements

1
H-Index
1
Papers
179
Total Citations
179
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial)
179 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: University Hospital Heidelberg

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago